Fungal Infections Archives - Page 2 of 16 - MPR

Fungal Infections

Novel Antifungal Gains Fast Track Designation for Seven Indications

The Food and Drug Administration (FDA) has granted Fast Track designations to both the oral and intravenous formulations of fosmanogepix (APX001; Amplyx Pharmaceuticals) for 7 antifungal indications, including treatment of: invasive candidiasis, invasive aspergillosis, scedosporiosis, fusariosis, mucormycosis, cryptococcosis and coccidioidomycosis. Fosmanogepix is a broad spectrum antifungal with a novel mechanism of action that has demonstrated…

New Drug Product: Tolsura

This slideshow reviews drug information for Tolsura. This slideshow reviews drug information for Tolsura.